All production operations are completed in isolators that meet Class A clean environmental standards

Has reached in-depth strategic cooperation with Xinbang Intelligent Equipment, and successfully introduced its self-developed multi-robot collaborative automation system to fully realize the intelligent upgrade of the production process of varicella and other active vaccines. This cooperation marks a major breakthrough in the transformation of the company from traditional manual operation to fully automated and digital manufacturing in the key links of biopharmaceuticals, and an important step in promoting the implementation of intelligent manufacturing. The intelligent system takes highly integrated engineering technology as the core, and constructs a set of fully enclosed and fully automatic intelligent operation system for cell culture, liquid treatment, material transfer and other complex processes that originally rely on manual completion. The whole production line is equipped with 12 aseptic six-axis industrial robots, which have excellent motion accuracy and efficient cooperative operation ability. They can accurately perform many core process tasks such as automatic loading and unloading of multi-layer cell factories, constant shaking culture, high-throughput liquid sub-packaging, etc., greatly improving the stability and consistency of the production process. All production operations are completed in an isolator that meets the-level clean environment standard, which completely realizes the physical isolation between personnel and the production area, effectively avoids the risk of pollution caused by human intervention, and significantly reduces cross-contamination and biosafety exposure Hidden dangers further guarantee the sterility and safety of the product. The system is designed and implemented in strict accordance with GMP standards. Through standardized program control, real-time data collection and traceability management of the whole process, the system ensures that the quality of each batch of vaccines is controllable and the results are reliable, and the product compliance and quality management level are comprehensively improved. Thanks to the efficient and stable operation of the system, the annual production capacity of the enterprise has achieved leapfrog growth and steadily broken through millions of agents, which not only effectively meets the growing market demand, but also provides a replicable and popularized technology model for future production expansion. More importantly, the successful application of the automated system fills a number of technical gaps in the field of intelligent production of high-end biological agents in China, and provides a practical solution for large-scale and high-quality mass production of active vaccines and other biological drugs with extremely strict requirements on aseptic conditions. This landmark innovation practice is not only a key symbol of vaccine manufacturing moving towards intelligent manufacturing, but also fully demonstrates the technical strength and engineering capability of domestic intelligent equipment in precision control, aseptic process integration and complex system coordination. This cooperation has set a benchmark for the digital transformation and upgrading of the biomedical industry, leading the industrial chain to accelerate towards high-end and intelligent direction. Looking to the future, with the continuous integration of cutting-edge technologies such as artificial intelligence, big data, and the Internet of Things, Xinbang Intelligent Equipment will continue to be committed to providing pharmaceutical companies with safer, more efficient and smarter production solutions to help China's biomedical industry Achieve high-quality development and move towards a higher level of the global value chain.